Studies have shown that NK cells recognize ligands like PDL1, Gal-9, and CD112/CD155 on AML cells through their surface receptors PD-1, TIM3, and TIGIT, triggering inhibitory signaling pathways. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.